Aptose Biosciences Inc (NAS:APTO)
$ 0.179 0.001 (0.56%) Market Cap: 3.47 Mil Enterprise Value: -4.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Q3 2022 Aptose Biosciences Inc Earnings Call Transcript

Nov 01, 2022 / 09:00PM GMT
Release Date Price: $7.48 (+8.32%)
Operator

Good afternoon. My name is [Shandrelin], and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences conference call for the third quarter ending September 30, 2022. (Operator Instructions) As a reminder, this conference call is being recorded.

And I would like to take this time to introduce Ms. Susan Pietropaolo. Susan?

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, [Shandrelin]. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the third quarter ended September 30, 2022. Earlier today, Aptose issued a press release relating to these financial results. The news release, as well as related SEC filings are accessible on Aptose's website. Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO and Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer and Mr. Fletcher Payne, Senior Vice President and Chief Financial Officer.

Before we proceed, I would like to remind everyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot